PT-141 is a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound operates by enhancing specific receptors within the body, leading to improved sexual function. Preclinical studies have revealed that PT-141 has the potential to significantly manage a spectrum of sexual dysf